Xin Li

6PUBLICATIONS
7CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 12, 2026
Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide in Patients With Large Paroxysmal Nocturnal Hemoglobinuria Clones.

Qiangsheng Weng, Yajing Xu, Yan Chen

|Dec 18, 2025
Pomalidomide enhances CAR-T cell therapeutic efficacy and remodels immune microenvironment in lymphoid malignancies.

Yi Zhou, Yan Yu, Linzhi Xie

|Aug 26, 2025
Targeting of the CD161 Inhibitory Receptor Enhances Bone-Marrow-Resident Memory CD8+ T-Cell-Mediated Immunity against Multiple Myeloma.

Liwen Wang, Linzhi Xie, Yi Zhou

|Jan 09, 2025
Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma.

Qin Yang, Yinghong Zhu, Xingxing Jian

|Nov 29, 2024
BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma.

Yuhan Yan, Yixuan Tu, Qian Cheng

Pageof 1

Frequent Collaborators

1 joint publications

Gang An

1 joint publications

Lugui Qiu

1 joint publications

Wen Zhou

1 joint publications

Yan Chen